The George Shultz Innovation Fund Finals will feature startup teams who have been selected as finalists for potential investment from the George Shultz Innovation Fund. Each team will pitch to the Innovation Fund Advisory Committee, consisting of advisors, entrepreneurs, and industry experts. The George Shultz Innovation Fund provides up to $250,000 in co-investment funding for promising early-stage ventures in deep tech. The core mission of the Innovation Fund is to help scientific founders turn their innovations into ventures that advance cutting-edge technologies, generate significant financial returns, and create lasting impact for humankind.

The three startups pitching in the fall cycle are:

• CellCipher: developing process to use embryoid bodies to study environmental and chemical exposures on human cells, enabling drug discovery and personalized medicine
• NetMicroscope: disrupting network performance monitoring with state-of-the-art machine learning-driven approaches by integrating network performance metrics and providing intelligence to network operators
• INOFFA: developing a technology to restore natural ovarian function for women with Primary Ovarian Insufficiency (POI) and Polycystic Ovary Syndrome (PCOS).

You can read more about the fall finalists here.